Prevention of Progression in Chronic Liver Disease - An Update on SNMC (Stronger Neo-Minophagen C). In Honour of Hans Popper's 100th Birthday - Hardback - 2004

In several liver diseases, the underlying cause cannot always be eliminated. This is true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40 per cent of patients with HCV genotype 1 and up to 20 per cent of patients with genotype 2 or 3.
Year of publication: 2004
Pagination: 130 pages, biography
Format: Hardback
Serie: Falk Symposium
Editor: N. (Osaka University School of Medicine) Hiyashi, M. P. Manns